Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sarah Barbuto"'
Autor:
Fabio ANASTASIO, Giacomo PUCCI, Elisa SCARNECCHIA, Alessandro GONELLA, Sarah BARBUTO, Manuel CACCONE, Giulio ROSSI, Pierpaolo PARRAVICINI
Publikováno v:
Minerva Respiratory Medicine. 62
Autor:
Mariaimmacolata Preianò, Sarah Barbuto, Girolamo Pelaia, Luca Gallelli, Corrado Pelaia, Maria Teresa Busceti, Cecilia Calabrese, Alessandro Vatrella, Rocco Savino
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 54:25-30
Omalizumab is a humanized monoclonal antibody which binds to human immunoglobulins E (IgE), thus preventing their interactions with both high affinity and low affinity IgE receptors. Therefore, omalizumab is currently recommended for add-on biologica
Autor:
Giovanni Rolla, Pierluigi Paggiaro, Marco Caminati, Girolamo Pelaia, Claudia Crimi, Pia Foschino Maria, Vincenzo Patella, Sarah Barbuto, Gianenrico Senna, Stefano Aliberti, Nunzio Crimi, Manuela Latorre, Giselda Colombo, Giorgio L Colombo, Giuseppe Spadaro, Teresa Costantino Maria, Nicola Scichilone, Giovanni Passalaqua, Mariangiola Crivellaro, Massimo Triggiani, Enrico Heffler, Caterina Bucca, Francesco Menzella, Sergio Di Matteo, Eleonora Savi, Elisabetta Favero, Chiara Martinotti, Diego Bagnasco, Gabriella Guarnieri, Gianna Camiciottoli, Francesco Blasi, M D'Amato, GM Bruno, Francesca Puggioni, Paolo Solidoro, Carlo Lombardi, Giorgio Walter Canonica, Erminia Ridolo
Publikováno v:
World Allergy Organization Journal, Vol 12, Iss 1, Pp-(2019)
The World Allergy Organization Journal
The World Allergy Organization Journal
Background: Asthma is one of the most common non-communicable respiratory diseases, affecting about 6% of the general population. Severe asthma, even if afflicts a minority of asthmatics, drives the majority of costs of the disease. The aim of this s
Autor:
Paolo Cosma, Sarah Barbuto, Pierpaolo Parravicini, Giulio Rossi, Mirco Parravicini, Elisa Scarnecchia, Alessandro Fugagnoli, Fabio Anastasio
Publikováno v:
The European Respiratory Journal
article-version (AM) Accepted Manuscript
article-version (AM) Accepted Manuscript
Background Coronavirus disease 2019 (COVID-19) has spread worldwide determining a dramatic impact on the healthcare system. Aim of this study is to evaluate mid-term clinical impact of COVID-19 on respiratory function. Methods 379 patients were evalu
Autor:
Giovanni Rolla, Girolamo Pelaia, Mariangiola Crivellaro, Maria Teresa Costantino, Maria Pia Foschino, Enrico Heffler, Alice D'Adda, Carlo Lombardi, Gabriella Guarnieri, Pierluigi Paggiaro, Nunzio Crimi, Francesco Blasi, Eleonora Savi, Manuela Latorre, Carla Galeone, Nicola Scichilone, Giselda Colombo, Giorgio Walter Canonica, Giovanni Passalacqua, M D'Amato, Francesco Menzella, Vincenzo Patella, Francesca Puggioni, Roberta Parente, Paolo Solidoro, Giuseppe Spadaro, Sarah Barbuto, Erminia Ridolo, Elisabetta Favero, Matteo Bradicich, Marco Caminati, Gianna Camiciottoli, Gianenrico Senna
Background Severe Asthma Network in Italy (SANI) is a registry of patients recruited by accredited centers on severe asthma. Objective To analyze epidemiological, clinical, inflammatory, functional, and treatment characteristics of severe asthmatics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9371fecef853f51f9446ccb79f638226
http://hdl.handle.net/11567/933903
http://hdl.handle.net/11567/933903
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.